Teacher Retirement System of Texas Sells 66,755 Shares of Agilent Technologies, Inc. $A

Key Points

• Teacher Retirement System of Texas cut its stake in Agilent by 63.6%, selling 66,755 shares in Q4 and leaving 38,179 shares valued at $5.195 million.
• Several large institutions boosted positions—most notably Massachusetts Financial Services, which owns 14,147,601 shares worth about $1.93 billion—signaling continued institutional buying despite the TRS sale.
• Analysts have an average "Buy" rating with a $163.71 target; Agilent slightly missed quarterly EPS ($1.36 vs. $1.37), provided FY2026 guidance of 5.90–6.04 EPS, and pays a $0.255 quarterly dividend (0.9% yield).

Teacher Retirement System of Texas lowered its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 63.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 38,179 shares of the medical research company's stock after selling 66,755 shares during the period. Teacher Retirement System of Texas' holdings in Agilent Technologies were worth $5,195,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the stock. Massachusetts Financial Services Co. MA lifted its holdings in shares of Agilent Technologies by 13.8% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company's stock valued at $1,925,064,000 after purchasing an additional 1,713,216 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of Agilent Technologies by 4.8% in the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company's stock valued at $1,203,990,000 after purchasing an additional 433,342 shares in the last quarter. Generation Investment Management LLP lifted its holdings in shares of Agilent Technologies by 10.1% in the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company's stock valued at $816,043,000 after purchasing an additional 582,093 shares in the last quarter. Ameriprise Financial Inc. lifted its holdings in shares of Agilent Technologies by 15.1% in the third quarter. Ameriprise Financial Inc. now owns 2,708,591 shares of the medical research company's stock valued at $347,685,000 after purchasing an additional 354,480 shares in the last quarter. Finally, Troy Asset Management Ltd lifted its holdings in shares of Agilent Technologies by 0.3% in the third quarter. Troy Asset Management Ltd now owns 2,404,161 shares of the medical research company's stock valued at $308,574,000 after purchasing an additional 6,341 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on A shares. Weiss Ratings restated a "hold (c+)" rating on shares of Agilent Technologies in a report on Monday, December 29th. Evercore upgraded Agilent Technologies from an "in-line" rating to an "outperform" rating and raised their target price for the company from $155.00 to $160.00 in a report on Monday, January 5th. Morgan Stanley dropped their target price on Agilent Technologies from $180.00 to $160.00 and set an "overweight" rating on the stock in a report on Tuesday, March 3rd. Barclays dropped their target price on Agilent Technologies from $150.00 to $140.00 and set an "overweight" rating on the stock in a report on Tuesday, April 14th. Finally, Wells Fargo & Company dropped their target price on shares of Agilent Technologies from $175.00 to $165.00 and set an "overweight" rating on the stock in a research report on Thursday, February 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Buy" and an average target price of $163.71.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $115.60 on Monday. The business's fifty day simple moving average is $117.25 and its 200 day simple moving average is $133.13. The firm has a market capitalization of $32.67 billion, a P/E ratio of 25.52, a price-to-earnings-growth ratio of 2.43 and a beta of 1.30. Agilent Technologies, Inc. has a 12 month low of $104.10 and a 12 month high of $160.27. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts' consensus estimates of $1.37 by ($0.01). The business had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The business's revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st were issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date was Tuesday, March 31st. Agilent Technologies's dividend payout ratio (DPR) is 22.52%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.